Oxygen Biotherapeutics Going for GOLD |
 SHIL spin out company Aurum Biosciences Ltd and Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), have signed a long-term agreement to develop a better tool for defining the extent of injury in acute ischemic stroke and for treating this emergency in the important early hours after the attack. At the centre of the project is Aurum's patented GOLD MRI technology and Oxygen Biotherapeutics’ proprietary, perfluorocarbon-based Oxycyte emulsion, which is known for delivering large amounts of oxygen to the brain.
Oxygen Biotherapeutics will supply Oxycyte and provide scientific expertise to Aurum for the preclinical studies using GOLD MRI technology. Clinical trials in stroke are expected to follow. Read the Oxygen Biotherapeutics Press Release.
|
Vital Signs for SHIL Projects |
 The Association of Anaesthetists of Great Britain and Ireland (AAGBI) have recognised the innovative work carried out by two of their members involved in SHIL projects. A new prize for Innovation in Anaesthesia and Critical Care will be presented to joint winners Dr James Limb from Royal Hospital for Sick Children in Glasgow and Dr Graeme McLeod from Institute of Academic Anaesthesia, Ninewells Hospital & Medical School in Dundee.
The award is given by the Association of Anaesthetists of Great Britain and Ireland (AAGBI) at their Winter Scientific Meeting held in London. Applications for the award were open to all anaesthetists and intensivists with the emphasis on new ideas contributing to patient safety, high quality clinical care and improvements in the working environment.
For further information regarding collaboration and license opportunities for these innovative products contact Edward Staunton.
|
For the 7th consecutive year, projects from the NHS Scotland have been shortlisted for a prestigious Scottish Health Innovations Ltd Award for best innovation originating from NHS Scotland.
The winner will be announced at the Scottish Enterprise Life Sciences Annual Dinner at the Edinburgh International Conference Centre on the 9th of February.
The Nominees are;
Novel device for Monitoring of Ischaemia - Professor Alan Johnstone, NHS Grampian.
This is a novel technique for identifying the earliest signs of tissue damage. The innovative product will alert the surgeon during an operation that there is a lack of oxygen getting to the tissue, thus preventing further tissue damage which can lead to amputation and even death.
Air Trap Device - Dr Graham Bell from NHS Greater Glasgow and Clyde.
Known as Air Free, this device will prevent air entrainment or embolisms occurring in intravenous drips. This increases patient safety by reducing interruptions to infusions, disconnections of IV lines, and the potential for air embolism.
Prosthetic Disc Nucleus - Professor Douglas Wardlaw from NHS Grampian.
This innovation for the treatment of back pain will be performed by minimally invasive surgery. This will enable the patient to leave the hospital the day after surgery, rather than the current five day stay. The product returns a normal pain free range of movement to the patient..
|
Robotic Rehab Receives Rewards |
 Scottish Health Innovations were winners at the the coveted 2011 Genesis Awards. Scottish Health Innovations won the Medtech Innovation award for working to commercialise iPAM, a collaborative project between Dr Alastair Cozens, Consultant in Rehabilitation Medicine at Woodend Hospital in Aberdeen and the University of Leeds. iPAM is a robotic system which increases the opportunities for stroke patients to exercise their stroke affected upper limbs between their conventional therapy sessions.
Dr Nigel McLean commented "This award recognises the substantial effort put in by all the contributing parties, without them the project would never have reached such a mature stage. This award comes at a great time as we are entering a multi-centre clinical trial to help us towards our objective of taking this product to market and benefit patients more widely"
|
Greater Glasgow and Clyde Chairman's Award |
SHIL were delighted to be invited to sponsor the 2011 NHS Greater Glasgow and Clyde Chairman's award. For a second year running, SHIL have been involved in generating the shortlist of candidates and commending winners in the different categories.
Presenting the awards for the 2011 winners was Deputy First Minister for Scotland, Nicola Sturgeon MSP
In the Nursing category:
Kirsteen Casy, Margaret Gray & Mary Clark, Chris Kelly and Elsbeth McLatchie
In the Improving Health category:
Woodlands Centre Garden
Dental Services for Children with Autism
In the Environmental Category:
Glasgow City CHP (South Sector)
In the Clinical Practise category:
One stop shop allergy clinic
The overall winner of the Chairman's Award for Excellence:
Chris Kelly, Nurse Specialist for IBD from Paisley's Royal Alexandra Hospital.
|
SHIL welcomes new directors |
SHIL has welcomed 6 new directors onto its board. The new board reflects the continued commitment SHIL has to the regional healthboards in Scotland. Joining the board are Mike Stevens and Sara Davies (Chief Scientist Office), Chris Packard (Greater Glasgow and Clyde Health Board), David Reid (Grampian Health Board), Jill Belch (Tayside Health Board) and Julia Brown (Scottish Enterprise).
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
|
|
Page 1 of 7 |
